Business Wire

I-COM

30.9.2020 05:03:53 CEST | Business Wire | Press release

Share
Harm Reduction Policies Essential to Prevent Cancer, Say I-Com and MEPs

I-Com, the Institute for Competitiveness, yesterday hosted a landmark roundtable in the context of Europe’s Beating Cancer Plan, summarised here , bringing together policymakers from across the political spectrum, academics and scientists to present the findings of their study on best practices to beat cancer.

During the roundtable, the discussion analysed best practices and successes of harm reduction policies across Europe. Enabling citizens to live healthier lifestyles by making less risky products accessible, such as vaping devices for smokers, by conducting education and awareness campaigns about responsible alcohol consumption and by building infrastructure promoting physical activity are examples of the core ideas driving the evidence-based approach behind harm reduction policy. During the public consultations on the Beating Cancer Plan, 20% of submissions highlighted harm reduction’s potential role.

Dolors Montserrat, Hosting MEP and a member of the Special Cancer Committee, said:

“I want to thank I-Com for the study just published that highlights how prevention policies aimed at reducing risk factors have a lot of potential to help Europe beat cancer. The Special Cancer Committee and the European Parliament welcome the study findings aimed to contribute to the future actions orientation of the Beating Cancer Plan. Our wish is for the Parliament to play a key role in developing the Plan in effective and fruitful coordination with the European Commission.”

Commenting on the roundtable, Stefano da Empoli, President of I-Com, said:

“We were delighted to present our recommendations on how harm reduction can support the prevention of cancer. It is now clear that public health experts, policymakers and academics all support the inclusion of harm reduction policies to help prevent cancer and mitigate the harm caused by tobacco, alcohol and unhealthy diets. Legislators must, at all times, keep patients at the forefront of their minds. Now is the time to embrace harm reduction.”

Margratis Schinas, European Commissioner for Promoting the European Way of Life, said:

“Our aim for the Plan is that cancer should no longer mean chances
fading away, dropping out from projects, or stigmatisation.
Instead, one day, cancer shall mean accessible treatment, recovery
and, therefore, life opportunities for all affected people.
And this is possible. Up to 40% of cancers can be prevented.”

I-Com’s recommended best practices in minimising the harms caused by alcohol, tobacco and nutrition, include reducing the availability of alcohol, increasing the availability of smokeless tobacco products and building infrastructure promoting physical activity.

ABOUT I-COM

The Institute for Competitiveness (I-Com) is an Italian independent think tank based in Rome and Brussels, founded in 2005 by a group of scholars, professionals and managers. I-Com aims at influencing the public debate at the national, European and international level, analysing the most important drivers for competitiveness and growth.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Azul Addresses the Java Runtime Security Blind Spot Autonomous AI Can Now Exploit17.6.2026 15:00:00 CEST | Press release

Launches free JVM vulnerability risk assessment to give enterprises estate visibility before AI threat actors find the gaps Azul, the trusted leader in enterprise Java for today’s AI and cloud-first world, today launched a free JVM vulnerability risk assessment to address the blind spot that autonomous AI exploitation tools are increasingly able to find. With mean time to exploit (MTTE) collapsing from months to days or hours, the unmanaged Java estate has become an urgent enterprise security vulnerability. Azul’s assessment gives DevOps and SecOps teams complete visibility into the hidden risks embedded in the runtime of their Java estate before threat actors get there first, and is designed to complement the broader security, licensing and compliance solutions and services delivered by Azul’s trusted partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617352753/en/ Azul's JVM Vulnerability Risk Assessment dashboard

Fortegra Strengthens Actuarial Leadership with Appointment of Anthony Katz as SVP, Reserving17.6.2026 15:00:00 CEST | Press release

The Fortegra Group, Inc., a global specialty insurer, today announced the appointment of Anthony Katz as Senior Vice President, Reserving. Mr. Katz will lead Fortegra’s team of professional actuaries, with responsibility for reserving, credit insurance, statistical reporting, and key initiatives including IFRS 17. “Anthony brings more than 30 years of actuarial expertise and a genuine commitment to building the capabilities our distribution partners depend on,” said Rick Kahlbaugh, Chief Executive Officer at Fortegra. “His background across reserving, actuarial transformation, and international markets will be instrumental as we continue to support our distribution partners.” A credentialed actuary holding FCAS, FSA, and MAAA designations, Mr. Katz brings more than 30 years of experience across reserving, pricing, and actuarial transformation. He has held senior leadership roles at ToaRe, Everest Re, Arch Insurance, Ernst & Young, and ACE, and most recently served as an independent con

Hitachi Expands Its Work With OpenAI to Accelerate AI-Driven Modernization and Cybersecurity17.6.2026 15:00:00 CEST | Press release

Hitachi and OpenAI’s Forward Deployed Engineer (FDE) will begin developing AI solutions for legacy system modernization, starting with financial institutions, aiming to expand across a wide range of industries. Through OpenAI’s “Trusted Access for Cyber,” Hitachi will strengthen its internal cybersecurity in practice and leverage the insights gained from this initiative to enhance its cybersecurity capabilities. Through this work, Hitachi will enhance its FDE capabilities in modernization and cybersecurity and further advance HMAX. Hitachi, Ltd. (TSE:6501, "Hitachi") today announced that it will expand its work with OpenAI*1 to accelerate AI-driven modernization and cybersecurity. The work combines OpenAI’s frontier AI technology with Hitachi’s domain expertise and know-how in supporting mission-critical systems and social infrastructure to accelerate AI transformation (AX) for customers and society. Working together, the two companies’ FDE teams will leverage OpenAI’s AI agent “Codex”

Hologic’s New Sustainability Report Marks 40 Years of Impact17.6.2026 15:00:00 CEST | Press release

Report outlines actions helping to reduce environmental impact, advance health equity and engage a purpose-driven workforce Hologic, Inc., a global leader in women’s health, today released its 2025 Sustainability Report. The new report coincides with Hologic’s 40th anniversary and underscores how the company’s longstanding purpose — to enable healthier lives for women everywhere, every day — continues to drive progress for patients, communities and the planet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617160174/en/ Hologic 2025 Sustainability Report “We have always firmly believed that our success as a company is fundamentally tied to our ability and commitment to help women worldwide live healthier lives,” said Sharon Vidal, Chief Sustainability Officer at Hologic. “Together with our customers and partners, we’re taking measurable steps to increase global access to innovative medical technologies while pursuing a mo

Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy17.6.2026 14:39:00 CEST | Press release

Laprophan Group, the pioneer and one of Morocco's leading pharmaceutical groups, today announced the successful completion of the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company specialized in specialty medicines, dossier development, complex formulations and value-added pharmaceutical solutions, and operating its own industrial manufacturing site. The financial terms of the transaction were not disclosed. Rivopharm generates annual revenue of approximately US$100 million. The acquisition represents a transformational milestone in Laprophan's development and marks the Group's first acquisition in Europe. The transaction significantly strengthens Laprophan's European footprint and accelerates its ambition to build a differentiated international pharmaceutical platform spanning Europe, Africa, the Middle East and selected global markets. The acquisition was carried out through Europhan, Laprophan's Luxembourg-based European platform, reinforcin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye